Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

New type of drug shows promise for chronic lymphocytic leukemia

New type of drug shows promise for chronic lymphocytic leukemia

Discovery of inherited gene mutation for leukemia

Discovery of inherited gene mutation for leukemia

Knocking out Mcl1 protein could aid leukemia treatment

Knocking out Mcl1 protein could aid leukemia treatment

Researchers induce cell death in leukemia

Researchers induce cell death in leukemia

CuraGen announces results with Belinostat and Velafermin

CuraGen announces results with Belinostat and Velafermin

Turning the immune system against cancer

Turning the immune system against cancer

Roswell Park research aids development of myeloma drug

Roswell Park research aids development of myeloma drug

Scientists identify microRNAs that appear to play a role in the development of platelets

Scientists identify microRNAs that appear to play a role in the development of platelets

New and unusual class of genes plays an important role in the development of chronic lymphocytic leukemia

New and unusual class of genes plays an important role in the development of chronic lymphocytic leukemia

Experts on chronic lymphocytic leukemia (CLL) review current scientific knowledge

Experts on chronic lymphocytic leukemia (CLL) review current scientific knowledge

FDA accepts Genmab's Investigational New Drug Application for active rheumatoid arthritis treatment

FDA accepts Genmab's Investigational New Drug Application for active rheumatoid arthritis treatment

Obesity could more than double an older woman's risk of acute myelogenous leukemia

Obesity could more than double an older woman's risk of acute myelogenous leukemia

Microchip to track genetic signature of cancer and normal tissue

Microchip to track genetic signature of cancer and normal tissue

Results from study of Rituxan in rheumatoid arthritis show promise

Results from study of Rituxan in rheumatoid arthritis show promise

Green tea helps kill cells of the most common leukemia

Green tea helps kill cells of the most common leukemia